{"id":18190,"date":"2026-02-12T15:47:12","date_gmt":"2026-02-12T08:47:12","guid":{"rendered":"https:\/\/search.web.id\/digest\/emtk-bolsters-dominant-stake-in-same-sarana-meditama-metropolitan-a-strategic-future-move\/"},"modified":"2026-02-12T15:47:12","modified_gmt":"2026-02-12T08:47:12","slug":"emtk-bolsters-dominant-stake-in-same-sarana-meditama-metropolitan-a-strategic-future-move","status":"publish","type":"post","link":"https:\/\/search.web.id\/digest\/emtk-bolsters-dominant-stake-in-same-sarana-meditama-metropolitan-a-strategic-future-move\/","title":{"rendered":"EMTK Bolsters Dominant Stake in SAME (Sarana Meditama Metropolitan): A Strategic Future Move"},"content":{"rendered":"

Jakarta, Indonesia \u2013 In a significant forward-looking transaction, Elang Mahkota Teknologi (EMTK)<\/a>, the controlling entity behind Sarana Meditama Metropolitan Tbk (SAME)<\/a>, has announced a substantial increase in its ownership of the healthcare provider. This strategic acquisition, slated to occur between February 6-9, 2026, signals EMTK’s unwavering confidence and commitment to SAME’s future trajectory within Indonesia’s dynamic healthcare landscape.<\/p>\n

EMTK Fortifies Control: A Glimpse into Future Strategy<\/h2>\n

EMTK’s move to acquire an additional ~979.6 million shares of SAME underscores a clear strategic intent. Executed at an average price of Rp308 per share, this transaction represents a total investment nearing Rp302 billion. The acquisition details were officially reported via a KSEI announcement<\/a>, providing a transparent view of the forthcoming shift in ownership structure.<\/p>\n

Post-transaction, EMTK\u2019s direct ownership in SAME will ascend from an already substantial 79.00% to a more commanding 84.71%. This increase solidifies EMTK’s majority shareholder position, effectively tightening its grip and ensuring strong strategic alignment for SAME’s operations.<\/p>\n

What This Means for SAME (Sarana Meditama Metropolitan)<\/h2>\n

For Sarana Meditama Metropolitan, an integral player in Indonesia’s evolving healthcare sector, this enhanced commitment from EMTK is a powerful vote of confidence. Increased direct ownership often translates into greater operational stability and potentially swifter execution of strategic initiatives. As a publicly traded entity, SAME benefits from the clear backing of a robust parent company, which can facilitate long-term planning and capital allocation for expansion and service improvement.<\/p>\n

SAME operates hospitals and healthcare facilities, a sector experiencing significant growth and demand in Indonesia. EMTK’s deepened investment suggests a belief in SAME’s potential to capture further market share and innovate within this essential industry.<\/p>\n

Elang Mahkota Teknologi’s Vision: Investing in Growth<\/h2>\n

EMTK, a diversified conglomerate with interests spanning media, technology, and healthcare, strategically utilizes its investment prowess to foster growth across its portfolio companies. This upcoming stake increase in SAME aligns with EMTK’s broader vision of identifying and nurturing high-potential assets. By bolstering its position in SAME, EMTK signals its long-term commitment to the healthcare industry, viewing it as a cornerstone for future revenue streams and market influence.<\/p>\n

Market Implications and Investor Outlook<\/h3>\n

While the transaction is slated for 2026, its announcement provides an early indicator of EMTK’s strategic direction. Investors in both EMTK and SAME will likely interpret this move as a bullish signal for SAME’s prospects, backed by a financially powerful and strategically astute parent company. Such consolidation of ownership can often reduce uncertainty and enhance investor confidence, paving the way for sustained growth and value creation in the years to come.<\/p>\n

<\/strong>EMTK<\/a><\/span>SAME<\/a> <\/div>\n","protected":false},"excerpt":{"rendered":"

Jakarta, Indonesia \u2013 In a significant forward-looking transaction, Elang Mahkota Teknologi (EMTK), the controlling entity behind Sarana Meditama Metropolitan Tbk (SAME), has announced a substantial increase in its ownership of the healthcare provider. This strategic acquisition, slated to occur between February 6-9, 2026, signals EMTK’s unwavering confidence and commitment to SAME’s future trajectory within Indonesia’s […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[986],"tags":[188,415],"class_list":["post-18190","post","type-post","status-publish","format-standard","hentry","category-stock","tag-emtk","tag-same"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/search.web.id\/digest\/wp-json\/wp\/v2\/posts\/18190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/search.web.id\/digest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/search.web.id\/digest\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/search.web.id\/digest\/wp-json\/wp\/v2\/comments?post=18190"}],"version-history":[{"count":0,"href":"https:\/\/search.web.id\/digest\/wp-json\/wp\/v2\/posts\/18190\/revisions"}],"wp:attachment":[{"href":"https:\/\/search.web.id\/digest\/wp-json\/wp\/v2\/media?parent=18190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/search.web.id\/digest\/wp-json\/wp\/v2\/categories?post=18190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/search.web.id\/digest\/wp-json\/wp\/v2\/tags?post=18190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}